We know that we're likely to melt down when things get hectic, …
"At least two-thirds of all (study) participants underestimated…
Advertisement
NY bio co. gets $4.6M from Russia to develop drugs
Initiative focuses on anti-infection drugs
Updated: Wednesday, 28 Nov 2012, 4:35 PM EST
Published : Wednesday, 28 Nov 2012, 4:35 PM EST
BUFFALO, N.Y. (AP) - A western New York company says it has signed a $4.6 million contract with Russia to develop anti-infection drugs.
Buffalo-based Cleveland BioLabs Inc. says the contract with the Ministry of Industry and Trade of the Russian Federation was issued under the federation's "Pharma 2020" pharmaceutical development initiative.
The contract announced Tuesday focuses on Xenomycins, a family of compounds being developed as potential treatments for infectious diseases. It's being handled through Panacela Labs, a biotechnology startup company that was founded last year as a joint venture between Cleveland BioLabs and a Russian investment company.
 | With WDTN.com's new commenting system you don't need to register. You can login with an existing Facebook, Yahoo!, Google, or Twitter account and more. |
Email This
Print This
View Story on a Single Page
Advertisement
Mugshot Gallery
The following people have recently been booked into Jail. They may not have been convicted of the crimes they are charged with and are innocent until proven guilty.
Advertisement
Advertisement